THR-β modulator-1（compound 1a）是高效的甲状腺激素受体β（THR-β）调节剂，适用于甲状腺激素受体相关疾病的研究。

N-Desbutyl dronedarone is an active metabolite of the antiarrhythmic agent dronedarone .1,2,3It is formed from dronedarone by cytochrome P450s (CYPs) and monoamine oxidase (MAO) in human hepatocyte preparations.4N-Desbutyl dronedarone inhibits the binding of 3,3’,5-triiodo-L-thyronine to the thyroid hormone receptors TRα1and TRβ1(IC50s = 59 and 280 μM for the chicken and human receptors, respectively).1It inhibits CYP2J2-mediated formation of 14,15-EET from arachidonic acid and soluble epoxide hydrolase-mediated formation of 14,15-DHET from 14,15-EET (IC50s = 1.59 and 2.73 μM, respectively, in cell-free assays).2N-Desbutyl dronedarone decreases intracellular ATP levels in H9c2 rat cardiomyocytes (IC50= 1.07 μM) and inhibits mitochondrial complex I, also known as NADH dehydrogenase, and mitochondrial complex II, also known as succinate dehydrogenase, activities in isolated rat heart mitochondria (IC50s = 11.94 and 24.54 μM, respectively).3 1.Van Beeren, H.C., Jong, W.M.C., Kaptein, E.,

Azetirelin (YM 14673) 是一种新的促甲状腺激素释放激素 （TRH） 类似物。

TR antagonist 1 是一种高效甲状腺激素受体（TR）拮抗剂（对 TRα 和 TRβ 的 IC50 分别为 36 和 22 nM），可用于研究内分泌异常引起的疾病。

Propylthiouracil (6-n-Propylthiouracil) 是一种甲状腺过氧化物酶抑制剂，也是一种5'-脱碘酶抑制剂。

Eneboparatide(AZP-3601)是一种新型的PTHR1(甲状旁腺激素受体1)的肽激动剂，可用于研究甲状旁腺功能减退症(hypoparathyroidism)，控制患者的血清钙值。

Parathyroid hormone (PTH) receptor agonist. Increases serum PTH levels and bone mass in rats.

Rovatirelin (S-0373) 是一种新合成的促甲状腺激素释放激素（TRH）类似物，通过乙酰胆碱和多巴胺神经传递改善胞嘧啶阿拉伯糖苷诱导的脊髓小脑变性大鼠模型的运动功能障碍。

MB-07811 (VK-2809) 是 MB07344 的一种口服活性 HepDirect 前药，具有降低胆固醇和甘油三酯的活性。 MB-07811 是肝脏靶向甲状腺激素受体-β 的激动剂。